Related Experiment Video

Updated: May 10, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Retapamulin: a newer topical antibiotic

D Dhingra1, A Parakh, S Ramachandran

  • 1Department of Pediatrics, Lady Hardinge Medical College and Kalawati Saran Children's Hospital, New Delhi, India.

Journal of Postgraduate Medicine
|June 25, 2013
PubMed

Insights

Retapamulin offers a new topical treatment for childhood impetigo, showing high effectiveness against resistant bacteria like Staphylococcus aureus. This newer antibiotic has low resistance potential and a good safety profile for pediatric use.

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Pharmacology

Background:

  • Impetigo is a prevalent bacterial skin infection in children.
  • Increasing antibiotic resistance to topical fusidic acid and mupirocin is a growing concern.
  • Emerging drug-resistant strains of Staphylococcus aureus complicate treatment options.

Purpose of the Study:

  • To evaluate the efficacy and safety of retapamulin for treating impetigo in children.
  • To assess the potential for antibacterial resistance development with retapamulin.
  • To introduce retapamulin as a novel therapeutic option in the Indian market.

Main Methods:

  • Clinical evaluation of retapamulin's effectiveness in pediatric impetigo cases.
  • In vitro studies assessing potency against Gram-positive bacteria, including resistant strains.
  • Pharmacokinetic analysis to determine systemic absorption and safety profile.

Main Results:

  • Retapamulin demonstrates high potency against poly-drug resistant Gram-positive bacteria.
  • The drug exhibits low potential for developing antibacterial resistance.
  • Minimal local irritation was observed, with low systemic absorption indicating a favorable safety profile.

Conclusions:

  • Retapamulin is an effective and safe topical treatment for childhood impetigo.
  • Its low resistance potential makes it a valuable alternative to older antibiotics.
  • The drug's availability in India provides a new option for managing resistant skin infections.

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care11:06

Subretinal Implantation of RPE on a Carrier in Minipigs: Guidelines for Preoperative Preparations, Surgical Techniques, and Postoperative Care

Published on: November 11, 2022

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Hand hygiene01:23

Hand hygiene

Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...